<img alt="Vasiprak FNB Pvt Ltd" data-src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-2.svg" class="logo-dark lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-2.svg" alt="Vasiprak FNB Pvt Ltd" class="logo-dark" >

<img alt="Vasiprak FNB Pvt Ltd" data-src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-White-2.svg" class="logo-light lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-White-2.svg" alt="Vasiprak FNB Pvt Ltd" class="logo-light" >

Vasiprak FNB Pvt Ltd

Breaking Boundaries since 2018

Vasiprak Blog

Crigler-Najjar Syndrome Type 1

Moderna inks collaboration with ILCM to develop mRNA therapeutic for ultra-rare disease, Health News, ET HealthWorld

Cambridge, Massachusetts : Moderna and the nonprofit Institute for Life Changing Medicines (ILCM) announced a new collaboration to develop a new mRNA therapeutic (mRNA-3351) for Crigler-Najjar Syndrome Type 1 (CN-1),…